CompletedPhase 2NCT03332225
A Trial of Validation and Restoration of Immune Dysfunction in Severe Infections and Sepsis
Studying Macrophage activation syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Hellenic Institute for the Study of Sepsis
- Principal Investigator
- Antonios Papadopoulos, MD, PhDNational Kapodistrian University of Athens, Medical School
- Intervention
- Anakinra(drug)
- Enrollment
- 36 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2017 – 2019
Study locations (13)
- 2nd Department of Critical Care Medicine, Athens, Haidari, Greece
- 4th Department of Internal Medicine, Athens, Haidari, Greece
- Intensive Care Unit, Ioannina University Hospital, Ioannina, Ioannina, Greece
- Intensive Care Unit, Center for Accident Rehabilitation (KAT) of Athens, Athens, Kifissia, Greece
- Department of Internal Medicine, Patras University Hospital, Pátrai, Rion, Greece
- Intensive Care Unit, Alexandroupolis University Hospital, Alexandroupoli, Greece
- 1st Department of Pulmonary Medicine and Intensive Care Unit, Athens, Greece
- Intensive Care Unit, "Latsio", Thriasio Elefsis General Hospital, Elefsina, Greece
- Intensive Care Unit, "Koutlimbaneio & Triantafylleio" Larissa General Hospital, Larissa, Greece
- Department of Internal Medicine, Larissa University Hospital, Larissa, Greece
- Intensive Care Unit, "Tzanio" Piraeus General Hospital, Piraeus, Greece
- Intensive Care Unit, "Aghios Dimitrios" Thessaloniki General Hospital, Thessaloniki, Greece
- Intensive Care Unit, "G.Gennimatas" Thessaloniki General Hospital, Thessaloniki, Greece
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03332225 on ClinicalTrials.gov